title: Oxaprozin: a new NSAID.
abstract: Oxaprozin, a propionic acid derivative, is a non-steroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties. Its spectrum of anti-inflammatory activity has been demonstrated in both in vitro and in vivo models.1 The majority of published clinical trials have focused on the use of oxaprozin (from Searle) in the treatment of osteoarthritis and rheumatoid arthritis.
authors.affiliation: School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia.
authors.forename: M A
authors.initials: MA
authors.lastname: al-Faks
authors.forename: M C
authors.initials: MC
authors.lastname: Pugh
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004311:Double-Blind Method; D006207:Half-Life; D006801:Humans; D010003:Osteoarthritis / Q000188:drug therapy*; D000077431:Oxaprozin; D011422:Propionates / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D011422:Propionates; D000077431:Oxaprozin